MORRIS TOWNSHIP, N.J.,
Aug. 2, 2011 /PRNewswire/ --
Honeywell (NYSE: HON) today announced that it has received early
termination of the waiting period under the Hart-Scott Rodino
Antitrust Improvements Act of 1976, as amended (the "HSR Act"), in
connection with the previously-announced cash tender offer made by
Egret Acquisition Corp., a wholly-owned subsidiary of Honeywell, to
purchase all of the outstanding shares of common stock of EMS
Technologies, Inc. (NASDAQ: ELMG), including the associated common
stock purchase rights, at a price of $33.00 per share, without interest and net of
applicable withholding taxes. Honeywell also has received the
required foreign antitrust approval in Austria in connection with the tender
offer.
The early termination of the waiting period under the HSR Act
satisfies one of the conditions for consummation of the tender
offer. The tender offer continues to be subject to the
satisfaction of other conditions, including the receipt of Canadian
antitrust approval and Federal Communications Commission
approvals.
As previously announced, the tender offer is scheduled to expire
at 5:30 p.m., New York City time, on Friday, August 19, 2011. The tender offer
may be extended pursuant to the procedures described in the Offer
to Purchase with respect to the tender offer.
IMPORTANT NOTICE: This press release is neither an offer to
purchase nor a solicitation of an offer to sell shares of EMS
Technologies, Inc. (EMS). The tender offer is being made
pursuant to a tender offer statement as amended and related
materials (including the Offer to Purchase and the Letter of
Transmittal). EMS STOCKHOLDERS ARE URGED TO READ BOTH THE
TENDER OFFER STATEMENT ON SCHEDULE TO AND RELATED MATERIALS
(INCLUDING THE OFFER TO PURCHASE AND LETTER OF TRANSMITTAL), AS
AMENDED, AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE
14D-9, AS AMENDED, REGARDING THE TENDER OFFER BECAUSE THEY CONTAIN
IMPORTANT INFORMATION. The tender offer statement on Schedule
TO and related materials, including the Offer to Purchase and
Letter of Transmittal, have been filed by Honeywell and Egret
Acquisition Corp. with the SEC and mailed to EMS stockholders.
The solicitation/recommendation statement on Schedule 14D-9
has been filed by EMS Technologies, Inc. with the SEC and mailed to
EMS stockholders. Investors and security holders may obtain
these statements and other documents at no charge from the SEC
through its website at www.sec.gov. Free copies of the tender offer
statement and related materials may also be obtained by directing a
request to D.F. King & Co.,
Inc., 48 Wall Street, 22nd Floor, New
York, NY 10005 or by calling toll-free (800) 290-6429.
Honeywell (www.honeywell.com) is a Fortune 100 diversified
technology and manufacturing leader, serving customers worldwide
with aerospace products and services; control technologies for
buildings, homes, and industry; automotive products; turbochargers;
and specialty materials. Based in Morris
Township, N.J., Honeywell's shares are traded on the
New York, London, and Chicago Stock Exchanges. For more
news and information on Honeywell, please visit
www.honeywellnow.com.
This release contains certain statements that may be deemed
"forward-looking statements" within the meaning of Section 21E of
the Securities Exchange Act of 1934. All statements, other than
statements of historical fact, that address activities, events or
developments that we or our management intends, expects, projects,
believes or anticipates will or may occur in the future are
forward-looking statements. Such statements are based upon certain
assumptions and assessments made by our management in light of
their experience and their perception of historical trends, current
economic and industry conditions, expected future developments and
other factors they believe to be appropriate. The forward-looking
statements included in this release are also subject to a number of
material risks and uncertainties, including but not limited to
economic, competitive, governmental, and technological factors
affecting our operations, markets, products, services and prices.
Other risks and uncertainties relating to the tender offer and
acquisition of EMS include the satisfaction of closing conditions
for the acquisition, including the tender of the requisite number
of the outstanding shares of EMS common stock, the possibility that
the acquisition will not be completed, or if it is completed that
it will not close within the anticipated time period, or that any
anticipated benefits of the acquisition to Honeywell will not be
realized. Such forward-looking statements are not guarantees of
future performance, and actual results, developments and business
decisions may differ from those envisaged by such forward-looking
statements.
Contacts:
|
|
|
Media
|
Investor
Relations
|
|
Robert C. Ferris
|
Elena Doom
|
|
(973) 455-3388
|
(973) 455-2222
|
|
rob.ferris@honeywell.com
|
elena.doom@honeywell.com
|
|
|
|
SOURCE Honeywell